Wuhan Keqian Biology Co.,Ltd announcement, the company's application for the pig pseudorabies live vaccine (strain HB-98, suspended culture) has been approved by the Ministry of Agriculture and Rural Affairs as a new veterinary drug, and issued the "New Veterinary Drug Registration Certificate". The vaccine is used to prevent pig pseudorabies, with an immunity period of 6 months. This approval will enrich the company's product variety, enhance market competitiveness, and have a positive impact on the company's operation and development.
科前生物:获批新兽药注册证书
Wuhan Keqian Biology Co.,Ltd: Obtained a new veterinary drug registration certificate.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.